MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway.
Li GZ, Meng GX, Pan GQ, Zhang X, Yan LJ, Li RZ, Ding ZN, Tan SY, Wang DX, Tian BW, Yan YC, Dong ZR, Hong JG, Li T.
Li GZ, et al. Among authors: li t, li rz.
Cancer Cell Int. 2023 Aug 31;23(1):188. doi: 10.1186/s12935-023-03034-1.
Cancer Cell Int. 2023.
PMID: 37653482
Free PMC article.